Table 2.
Male | Female | 0R | 95 % CI | p-value | |||
---|---|---|---|---|---|---|---|
Home | 128 | (68.1) | 162 | (54.0) | 1.81 | 1.24-2.66 | 0.002 |
Clinic | 36 | (19.2) | 102 | (34.0) | 0.46 | 0.30-0.71 | <0.001 |
VCT | 24 | (12.8) | 36 | (12.0) | 1.07 | 0.62-1.86 | 0.796 |
Male | Female | 0R | 95 % CI | p-value | |||
---|---|---|---|---|---|---|---|
Home | 128 | (68.1) | 162 | (54.0) | 1.81 | 1.24-2.66 | 0.002 |
Clinic | 36 | (19.2) | 102 | (34.0) | 0.46 | 0.30-0.71 | <0.001 |
VCT | 24 | (12.8) | 36 | (12.0) | 1.07 | 0.62-1.86 | 0.796 |